triazoles has been researched along with tigecycline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hussar, DA | 1 |
Choi, MY; Cook, DR; Elledge, SJ; Haigis, KM; Li, MZ; Martin, TD | 1 |
Correia, C; Dowdy, SC; Ekstrom, TL; Heinzen, EP; Hitosugi, T; Hou, X; Huntoon, CJ; Kanakkanthara, A; Karnitz, LM; Kaufmann, SH; Kurmi, K; Li, H; O'Brien, D; Oberg, AL; Purfeerst, ER; Wahner Hendrickson, AE; Weroha, SJ | 1 |
3 other study(ies) available for triazoles and tigecycline
Article | Year |
---|---|
New drugs 06, part II.
Topics: Analgesics; Benzeneacetamides; Benzoates; Bone Density Conservation Agents; Deferasirox; Diphosphonates; Docosahexaenoic Acids; Drug Approval; Drug Combinations; Drug Interactions; Drug Monitoring; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Eicosapentaenoic Acid; gamma-Aminobutyric Acid; Humans; Ibandronic Acid; Iloprost; Indenes; Minocycline; Patient Education as Topic; Phenylacetates; Pregabalin; Tigecycline; Triazoles; Vasodilator Agents | 2006 |
A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells.
Topics: Animals; Cell Line; Cell Proliferation; Clustered Regularly Interspaced Short Palindromic Repeats; Female; Genes, ras; HCT116 Cells; Humans; Hydrazones; Mice; Mice, Inbred BALB C; Minocycline; Mutation; NADH Dehydrogenase; Proto-Oncogene Proteins; Tigecycline; Triazoles; Xenograft Model Antitumor Assays | 2017 |
BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cyclin-Dependent Kinases; DNA Methylation; Energy Metabolism; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrazones; Hydroxybenzoates; Mice; Mitochondria; Mutation; Nicotinamide N-Methyltransferase; Ovarian Neoplasms; Ovary; Oxidative Phosphorylation; Promoter Regions, Genetic; Tigecycline; Triazoles; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |